0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma

Published: Reading: 1 min

Topic overview

This study compares parenchyma-sparing resection (PSR) to standard resection techniques for hepatoblastoma, examining whether tissue-conserving approaches can achieve comparable oncologic outcomes. The research addresses an evolving surgical paradigm in pediatric liver tumor management.

Key takeaways

  • Surgery remains the primary curative treatment for hepatoblastoma in pediatric patients.
  • Parenchyma-sparing resection is gaining acceptance as an alternative to traditional hemi-hepatectomy or trisectionectomy.
  • PSR aims to preserve functional liver tissue while achieving oncologic control in hepatoblastoma cases.
  • Comparative outcomes data between PSR and standard resection approaches are needed to guide surgical decision-making.

Keywords

Hepatoblastoma Parenchyma-sparing Resection Pediatric Oncology Liver Surgery Hepatectomy Surgical Outcomes

Hashtags

#Hepatoblastoma #PediatricOncology #LiverSurgery #ParenchymaSparing

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma. GlobalCastMD Medical Library. 2026-05-05. https://library.globalcastmd.com/article/12001

Comments

Loading comments...